Standard
Half-Life Extending Modifications of Peptide YY3-36 Direct Receptor-Mediated Internalization. / Bech, Esben M.; Kaiser, Anette; Bellmann-Sickert, Kathrin; Nielsen, Søren S.-R.; Sørensen, Kasper K.; Elster, Lisbeth; Hatzakis, Nikos; Pedersen, Søren L.; Beck-Sickinger, Annette G.; Jensen, Knud J.
In:
Molecular Pharmaceutics, Vol. 16, No. 8, 2019, p. 3665-3677.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Bech, EM, Kaiser, A, Bellmann-Sickert, K, Nielsen, SS-R, Sørensen, KK, Elster, L
, Hatzakis, N, Pedersen, SL, Beck-Sickinger, AG
& Jensen, KJ 2019, '
Half-Life Extending Modifications of Peptide YY3-36 Direct Receptor-Mediated Internalization',
Molecular Pharmaceutics, vol. 16, no. 8, pp. 3665-3677.
https://doi.org/10.1021/acs.molpharmaceut.9b00554APA
Bech, E. M., Kaiser, A., Bellmann-Sickert, K., Nielsen, S. S-R., Sørensen, K. K., Elster, L.
, Hatzakis, N., Pedersen, S. L., Beck-Sickinger, A. G.
, & Jensen, K. J. (2019).
Half-Life Extending Modifications of Peptide YY3-36 Direct Receptor-Mediated Internalization.
Molecular Pharmaceutics,
16(8), 3665-3677.
https://doi.org/10.1021/acs.molpharmaceut.9b00554Vancouver
Bech EM, Kaiser A, Bellmann-Sickert K, Nielsen SS-R, Sørensen KK, Elster L et al.
Half-Life Extending Modifications of Peptide YY3-36 Direct Receptor-Mediated Internalization.
Molecular Pharmaceutics. 2019;16(8):3665-3677.
https://doi.org/10.1021/acs.molpharmaceut.9b00554Author
Bech, Esben M. ; Kaiser, Anette ; Bellmann-Sickert, Kathrin ; Nielsen, Søren S.-R. ; Sørensen, Kasper K. ; Elster, Lisbeth ; Hatzakis, Nikos ; Pedersen, Søren L. ; Beck-Sickinger, Annette G. ; Jensen, Knud J. / Half-Life Extending Modifications of Peptide YY3-36 Direct Receptor-Mediated Internalization. In: Molecular Pharmaceutics. 2019 ; Vol. 16, No. 8. pp. 3665-3677.
Bibtex
@article{152af63d9f66489aa5d5e82cff0515d0,
title = "Half-Life Extending Modifications of Peptide YY3-36 Direct Receptor-Mediated Internalization",
keywords = "pharmacodynamics, PYY3-36, Y2 receptor, signaling, internalization, lipidation",
author = "Bech, {Esben M.} and Anette Kaiser and Kathrin Bellmann-Sickert and Nielsen, {S{\o}ren S.-R.} and S{\o}rensen, {Kasper K.} and Lisbeth Elster and Nikos Hatzakis and Pedersen, {S{\o}ren L.} and Beck-Sickinger, {Annette G.} and Jensen, {Knud J.}",
year = "2019",
doi = "10.1021/acs.molpharmaceut.9b00554",
language = "English",
volume = "16",
pages = "3665--3677",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "8",
}
RIS
TY - JOUR
T1 - Half-Life Extending Modifications of Peptide YY3-36 Direct Receptor-Mediated Internalization
AU - Bech, Esben M.
AU - Kaiser, Anette
AU - Bellmann-Sickert, Kathrin
AU - Nielsen, Søren S.-R.
AU - Sørensen, Kasper K.
AU - Elster, Lisbeth
AU - Hatzakis, Nikos
AU - Pedersen, Søren L.
AU - Beck-Sickinger, Annette G.
AU - Jensen, Knud J.
PY - 2019
Y1 - 2019
KW - pharmacodynamics
KW - PYY3-36
KW - Y2 receptor
KW - signaling
KW - internalization
KW - lipidation
U2 - 10.1021/acs.molpharmaceut.9b00554
DO - 10.1021/acs.molpharmaceut.9b00554
M3 - Journal article
C2 - 31310716
VL - 16
SP - 3665
EP - 3677
JO - Molecular Pharmaceutics
JF - Molecular Pharmaceutics
SN - 1543-8384
IS - 8
ER -
